Celularity Inc. has announced a securities purchase agreement with certain investors for a private placement involving the issuance and sale of 739,286 shares of its Class A common stock at a purchase price of $1.40 per share. In conjunction with this agreement, the company has also revised the exercise price of certain warrants held by these investors to $2.50 per share and extended their expiration date to June 30, 2030. The transaction, expected to close during the week of July 21, 2025, is anticipated to generate gross proceeds of $1,035,000, which the company plans to use for working capital and general corporate purposes.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。